Literature DB >> 3495053

Suppression of B lymphocyte genesis in the bone marrow by systemic graft-versus-host reactions.

A Xenocostas, W S Lapp, D G Osmond.   

Abstract

The effects of systemic graft-versus-host (GVH) reactions on B lymphocyte production in the bone marrow of mice were examined by quantitating populations of pre-B cells and B lymphocytes. Acute and chronic GVH reactions were induced by injecting A strain lymphoid cells into either (C57BL/6 X A) F1 or (CBA X A) F1 mice, respectively. Control groups of F1 hybrid mice were given syngeneic lymphoid cells. By double immunofluorescence labeling for cytoplasmic mu heavy chains of IgM (c mu) and for surface mu (s mu) the absolute numbers of pre-B cells (c mu + s mu-) and B lymphocytes (s mu +) in the bone marrow and spleen were determined. During acute GVH reactions, the pre-B cells and B lymphocytes in the bone marrow fell rapidly in numbers and were almost absent from 16 days until the end of the 30-day experimental period. In the spleen, the number of B lymphocytes remained normal for 8 days, then fell to less than 2% of control values from 16 days onward. A similar initial decline in pre-B cells and B lymphocytes occurred during chronic GVH reactions. In long-term survivors of GVH reactions, pre-B cells and B lymphocytes began to reappear after 40 days and maintained normal numbers from 100 to 150 days. The antibody response of spleen cells to sheep red blood cells was lost during GVH reactions. However, this occurred even before B lymphocytes were eliminated and the response remained subnormal after B lymphocyte numbers had recovered. The results demonstrate that systemic GVH reactions markedly depress the normally active genesis of primary B lymphocytes in the bone marrow of the host, accounting in part for the associated state of humoral immunodeficiency.

Entities:  

Mesh:

Year:  1987        PMID: 3495053     DOI: 10.1097/00007890-198704000-00019

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function.

Authors:  M B Baker; R L Riley; E R Podack; R B Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

2.  Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model.

Authors:  Rupal Pandey; Venkatesh L Hegde; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2011-06-14       Impact factor: 4.030

3.  Complete sequential regeneration of graft-vs.-host-induced severely dysplastic thymuses. Implications for the pathogenesis of chronic graft-vs.-host disease.

Authors:  T Ghayur; T A Seemayer; A Xenocostas; W S Lapp
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

4.  Prevention of murine acute graft-versus-host disease by staphylococcal enterotoxin B treatment.

Authors:  K Takenaka; Y Fujiyama; A Andoh; T Sasaki; Y Amakata; H Matsubara; K Hodohara; T Bamba
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

5.  IFN-gamma abrogates IL-7-dependent proliferation in pre-B cells, coinciding with onset of apoptosis.

Authors:  B A Garvy; R L Riley
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.